Oxidative stress as a signaling mechanism of the vascular response to injury: The redox hypothesis of restenosis

Cardiovascular Research

Volumn 47, Issue 3, 2000, Pages 436-445

  Azevedo, Luciano C P ^a   Pedro, Marcelo De A ^a   Souza, Liliete C ^a,b   De Souza, Heraldo P ^a   Janiszewski, Mariano ^a   Da Luz, Protásio L ^a   Laurindo, Francisco R M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Angioplasty; Atherosclerosis; Endothelial factors; Free radicals; Restenosis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CILOSTAZOL; FREE RADICAL; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEVINOLIN; PROBUCOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE;

ANGIOPLASTY; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CLINICAL TRIAL; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASOSPASM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTIOXIDANTS; CELL DIVISION; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RABBITS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SIGNAL TRANSDUCTION; TUNICA INTIMA;

EID: 0034683079     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00091-2     Document Type: Review

References (77)

1. O'Brien E.R., Schwartz S.M. Update on the biology and clinical study of restenosis. Trends Cardiovasc Med. 4:1994;349-356.
2. Libby P., Tanaka H. The molecular basis of restenosis. Progr Cardiovasc Dis. 40:1997;97-106.
3. Gibbons G.H., Dzau V.P. The emerging concept of vascular remodeling. N Engl J Med. 330:1994;1431-1438.
4. Pollman M.J., Hall J.L., Gibbons G.H. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. Circ Res. 84:1999;113-121.
5. Strauss B.H., Chisholm R.J., Keeley F.W., et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 75:1994;650-658.
6. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular metaloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 98:1996;2572-2579.
7. Schwartz S.M. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest. 99:1997;2814-2817.
8. Bauters C., Isner J.M. The biology of restenosis. Progr Cardiovasc Dis. 40:1997;107-116.
9. Faxon D.P., Coats W., Currier J. Remodeling of the coronary artery after vascular injury. Progr Cardiovasc Dis. 40:1997;129-140.
10. Abe J.I., Berk B.C. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med. 8:1998;59-63.
11. Susuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med. 22:1997;269-285.
12. Sen C.K., Packer L. Antioxidant and redox regulation of gene expression. FASEB J. 10:1996;709-720.
13. Kunsch C., Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 85:1999;753-766.
14. Libby P., Ganz P. Restenosis revisited - new targets, new therapies. New Engl J Med. 337:1997;418-419.
15. Laurindo F.R.M., da Luz P.L., Uint L., et al. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation. 83:1991;1705-1715.
16. Nunes G.L., Sgoutas D.S., Redden R.A., et al. Combinations of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol. 15:1995;156-165.
17. - production in pig coronary arteries. Circulation. 96:1997;3593-3601.
18. Lafont A.M., Chai Y.-C., Cornhill J.F., et al. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest. 95:1995;1018-1025.
19. Konneh M.K., Rutherford C., Li S.R., Änggard E., Ferns G.A.A. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. Atherosclerosis. 113:1995;29-39.
20. Ferns G.A., Forster L., Stewart-Lee A., et al. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc Natl Acad Sci USA. 89:1992;11312-11316.
21. Freyschuss A., Stiko R.A., Swedenborg J., et al. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest. 91:1993;1282-1288.
22. Schneider J.E., Berk B.C., Gravanis M.B., et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation. 88:1993;627-628.
23. Miyauchi K., Aikawa M., Tani T., et al. Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of PDGF. Cardiovasc Drugs Ther. 12:1998;251-260.
24. Tanaka K., Hayashi K., Shingu T., et al. Probucol inhibits neointimal formation in carotid arteries of normocholesterolemic rabbits and the proliferation of cultured rabbit vascular smooth muscle cells. Cardiovasc Drugs Ther. 12:1998;19-28.
25. Gong K.W., Zhu G.Y., Wang L.H., Tang C.S. Effect of active oxygen species on intimal proliferation in rat aorta after arterial injury. J Vasc Res. 33:1996;42-46.
26. Wohlfrom M., Hanke S., Kamenz J., et al. Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty. Coron Artery Dis. 9:1998;831-837.
27. Burchenal J.E., Keaney J.F. Jr, Curran-Celentano J., et al. The lack of effect of beta-carotene on restenosis in cholesterol-fed rabbits. Atherosclerosis. 123:1996;157-167.
28. Feng A.N., Chen Y.L., Ding Y.Z., Lin S.J. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits. Circulation. 100:1999;2254-2259.
29. Speir E., Shibutani T., Yu Z.X., Ferrans V., Epstein S.E. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in response of human smooth muscle cells to viral infection. Circ Res. 79:1996;1143-1152.
30. Janiszewski M., Pasqualucci C.A., Souza L.C., et al. Oxodized thiols markedly amplify the vascular response to balloon injury in rabbits through a redox active metal-dependent pathway. Cardiovasc Res. 39:1998;327-338.
31. Tardif J.C., Coté G., Lesperance J., et al. Probucol and multivitamins in the prevention of reestenosis after coronary angioplasty. N Engl J Med. 337:1997;365-372.
32. Lee Y.J., Daida H., Yokoi H., et al. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty. Jpn Heart J. 37:1996;327-332.
33. Setsuda M., Inden M., Hiraoka N., et al. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty. Clin Ther. 15:1993;374-382.
34. Yokoi H., Daida H., Kuwabara Y., et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol. 30:1997;855-862.
35. Watanabe K., Sekiya M., Ikeda S., Miyagawa M., Hashida H. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J. 132:1996;23-29.
36. O'Keefe J.H. Jr., Stone G.W., McCallister B.D. Jr., et al. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 77:1996;649-652.
37. Sekiya M., Funada J., Watanabe K., Miyagawa M., Akutsu H. Effects of probucol and cilostazol alone and in combination on frequency of post-stenting restenosis. Am J Cardiol. 82:1998;144-147.
38. Rodés J., Côté G., Lespérance J., et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation. 97:1998;429-436.
39. Cote G., Tardif J.C., Lesperance J., et al. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group. Circulation. 99:1999;30-35.
40. Marks D.S., Vita J.A., Folts J.D., et al. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest. 96:1995;2630-2638.
41. Souza HP, Souza LC, Anastacio VM, et al. Vascular oxidant stress early after balloon injury. Evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med 2000;in press.
42. Griendling K., Ushio-Fukai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med. 7:1997;301-307.
43. Patterson C., Ruef J., Madamanchi N.R., et al. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47phox may participate in forming this oxidase in vitro and in vivo. J Biol Chem. 274:1999;19814-19822.
44. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., et al. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA. 94:1997;14483-14488.
45. Suh Y.-A., Arnold R.S., Lassegue B., et al. Cell transformation by the superoxide-generating oxidase Mox 1. Nature. 401:1999;79-82.
46. De Keulenaer G., Chappell D.C., Ishizaka N., et al. Oscillatory and laminar shear stress differentially affect human endothelial redox state. Role of a superoxide-producing NADH oxidase. Circ Res. 82:1998;1094-1101.
47. Janiszewski M., Pedro M.A., Laurindo F.R.M. Reactive thiols affect vascular NAD(P)H oxidase: evidence for two different enzyme activity profiles. FASEB J. 13:1999;A862. abstract.
48. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease: an overview. Meth Enzymol. 186:1990;1-85.
49. Evans P.J., Smith C., Mitchinson M., Halliwell B. Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. Free Rad Res. 23:1995;465-469.
50. Arbault S., Pantano P., Sojic N., et al. Activation of the NADPH oxidase in human fibroblasts by intrusion of a single cell with an ultramicroelectrode. Carcinogenesis. 18:1997;569-574.
51. Laurindo F.R.M., Pedro M.A., Barbeiro H.V., et al. Vascular free radical release: ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res. 70:1994;700-709.
52. Howard A.B., Alexander R.W., Nerem R.M., Griendling K.K., Taylor R. Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol. 272:1997;C421-C427.
53. Serrano C.V. Jr., Ramires J.A., Venturinelli M., et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol. 29:1997;1276-1283.
54. De Servi S., Mazzone A., Ricevuti G., et al. Granulocyte activation after coronary angioplasty in humans. Circulation. 82:1990;140-146.
55. Tanaka H., Sukhova G., Swanson S.J., et al. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 88:1993;1788-1803.
56. Janiszewski M., Laurindo F.R.M., Pasqualucci C.A., da Luz P.L., Pileggi F. Effects of a single heparin bolus on neointimal growth after arterial injury in intact rabbits. Angiology. 47:1996;349-356.
57. Tarpey M.M., White C.R., Suarez E., et al. Chemiluminescent detection of oxidants in vascular tissue: lucigenin but not coelenterazine enhances superoxide formation. Circ Res. 84:1999;1203-1211.
58. Skatchkov M.P., Sperling D., Hink U., Anggard E., Munzel T. Quantification of superoxide radical formation in intact vascular tissue using a Cypridina luciferin analog as an alternative to lucigenin. Biochem Biophys Res Commun. 248:1998;382-386.
59. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 97:1996;1916-1923.
60. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Meister A. Methods in enzymology. vol. 113:1985;548-555 Academic Press, New York.
61. Akerboom T.P.M., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Jakobi W.B. Methods in enzymology. vol. 77:1981;373-382 Academic Press, New York.
62. Inoue N., Ramasamy S., Fukai T., Nerem R.M., Harrison D.G. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res. 79:1996;32-37.
63. Warnholtz A., Nickening G., Schulz E., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 99:1999;2027-2033.
64. McIntyre M., Bohr D.F., Dominiczak A.F. Endothelial function in hypertension: the role of superoxide anion. Hypertension. 34:1999;539-545.
65. Laursen J.B., Rajagopalan S., Galis Z., et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 95:1997;588-593.
66. Vásquez-Vivar J., Hogg N., Pritchard K.A., Martasek P., Kalyanaraman B. Superoxide anion formation from lucigenin: an electron spin resonance spin-trapping study. FEBS Lett. 403:1997;127-130.
67. Liochev S.I., Fridovich I. Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production. Arch Biochem Biophys. 337:1997;115-120.
68. Li Y., Zhu H., Kuppusamy P., et al. Validation of lucigenin (bis-N-methylacridinium) as a chemiluminescent probe for detecting superoxide anion radical production by enzymatic and cellular sources. J Biol Chem. 273:1998;2015-2023.
69. Skatchkov M.P., Sperling D., Hink U., et al. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun. 254:1999;319-324.
70. Liochev S.I., Fridovich I. Lucigenin luminescence as a measure of intracellular superoxide dismutase activity in Escherichia coli. Proc Natl Acad Sci USA. 94:1997;2891-2896.
71. González-Fernández F., López-Farré A., Rodríguez-Feo J., et al. Expression of inducible nitric oxide synthase after endothelial denudation of the rat carotid artery. Role of platelets. Circ Res. 83:1998;1080-1087.
72. Poppa V., Miyashiro J.K., Corson M.A., Berk B.C. Endothelial NO synthase is increased in regenerating endothelium after denuding injury of the rat aorta. Arteriocler Thromb Vasc Biol. 18:1998;1312-1321.
73. Lindner V., Collins T. Expression of NF-κB and IκB-α by aortic endothelium in an arterial injury model. Am J Pathol. 148:1996;427-438.
74. Cercek B., Yamashita M., Dimayuga P., et al. Nuclear factor - κB activity and arterial response to balloon injury. Atherosclerosis. 131:1997;59-66.
75. Landry D.B., Couper L.L., Bryant S.R., Lindner V. Activation of the NF-κB and IκB system in smooth muscle cells after rat arterial injury. Am J Pathol. 151:1997;1085-1095.
76. Berlett B., Stadtman E.R. Protein oxidation in aging, disease and oxidative stress. J Biol Chem. 272:1997;20313-20316.
77. White C.R., Darley-Usmar V., Berrington W.R., et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA. 93:1996;8745-8749.